[Clinical application of calcimimetics]
Related Experiment Video
Updated: Aug 20, 2026

Calcium Imaging In Electrically Stimulated Flat-Mounted Retinas
Published on: August 18, 2023
Hiroshi Nishi1, Masafumi Fukagawa
1Division of Nephrology and Dialysis Center, Kobe University School of Medicine.
Abstract:
Calcimimetic agents modulate the activity of calcium-sensing receptor on the surface of parathyroid cell and suppress the secretion of parathyroid hormone. Several clinical trials demonstrated that the second-generation calcimimetics cinacalcet HCl reduced PTH level, as well as Ca x P product in secondary hyperparathyroidism, while the agents reduced PTH and calcium level in primary hyperparathyroidism.
Related Concept Videos
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Skeleton and Calcium Homeostasis
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Heart Failure Drugs: Inotropic Agents
